Results 251 to 260 of about 9,546,669 (393)

Combination therapy in rheumatoid arthritis

, 1992
Yōichi Ichikawa
openalex   +2 more sources

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

Personalized combination therapy for diffuse midline glioma: A case report. [PDF]

Oncol Lett
Sun M, Zheng J, Gong L, Li Z, Wang L.
europepmc   +1 more source

Therapeutic Evaluation of Combination Therapy using C-425, Human Native Immunoglobulin Liquid Preparation for i.v. Administration, with Antibiotics in Severe Infections in the Field of Surgery

, 1990
Yoshio Mishima, Toshinao INOUE, Hiroshi Hayasaka, Morio Totsuka, T Ebata, Ryoichi Motoki, Hitoshi Inoue, Yukio Endo, Shoetsu Tamakuma, Jun Imai, Yasuhiko Morioka, M Ishiyama, Chiyuki Watanabe, Kozaburo KIMURA, Shigekatsu KURIHARA, Atsushi NAKAZIMA, Kyuya Ishibiki, Naoki Aikawa, Hiroshi Takagi, N. Taira, Kazue Ozawa, Yasuyuki Shimahara, Takesada Mori, Junichi Kanbayashi, Yoichi Saito, Hiroyasu NISHIYAMA   +25 more
openalex   +2 more sources

Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism

Nature, 2019
Jiyoung Lee, Ali E. Yesilkanal, Joseph P. Wynne, C. Frankenberger, Juan Liu, Jie Yan, Mohamad Elbaz, D. Rabe, Felicia D Rustandy, P. Tiwari, Elizabeth A. Grossman, Peter C. Hart, Christie J. Kang, Sydney M. Sanderson, J. Andrade, Daniel K. Nomura, M. Bonini, J. Locasale, M. Rosner   +18 more
semanticscholar   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Antibiotic Tolerance and Combination Therapy

mBio, 2015
David C. Bean, Sarah M. Wigmore
doaj   +1 more source

Monotherapy and combination therapy using antibody‑drug conjugates for platinum‑resistant ovarian cancer. [PDF]

Oncol Rep
Shen K, Yuan S, Su N, Tang F, Rehim S, Wang H, Guo H, Zhang Y, Wu Y, Wang H.   +9 more
europepmc   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Patient With Advanced Aggressive B2 Thymoma Achieved Positive Outcomes Post CAP-Endostar Combination Therapy. [PDF]

Clin Respir J
Zhang M, Zhang J, Zhao K, Yuan X, Zhang J, Liu Y, Lu P.   +6 more
europepmc   +1 more source